Simplex Trading’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Other funds holding PDSB
QCM
MCM
Simplex Trading's PDSB Position: Q2 2026 in Review
Simplex Trading sold out of PDS Biotechnology (PDSB) in Q2 2026, closing a stake of 271 shares — an estimated $288 sold.
Simplex Trading first reported a position in PDSB in Q1 2018 and held it in 19 quarters. The position peaked at $217K in Q2 2023. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.
- Simplex Trading reported no remaining PDS Biotechnology position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 271 PDS Biotechnology shares in Q2 2026, an estimated $288.
- Simplex Trading first reported a position in PDS Biotechnology in Q1 2018 and held it in 19 quarters.
- Simplex Trading's PDS Biotechnology position peaked at $217K in Q2 2023.
- 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.